Abstract
In this issue of Blood, Gagne et al describe a cohort of 362 patients clinically classified as having Diamond-Blackfan anemia (DBA), in which 175 (48%) were found to have mutations and deletions in ribosomal protein genes or GATA1, and 8 of the remaining patients (2.2% overall) had mitochondrial gene deletions consistent with Pearson marrow-pancreas syndrome (PS). The authors propose that all patients with presumptive DBA should be tested for mitochondrial DNA (mtDNA) deletion during their initial genetic evaluation. 1.
Original language | English (US) |
---|---|
Pages (from-to) | 312-313 |
Number of pages | 2 |
Journal | Blood |
Volume | 124 |
Issue number | 3 |
DOIs | |
State | Published - Jul 17 2014 |
Externally published | Yes |
ASJC Scopus subject areas
- Hematology
- Biochemistry
- Cell Biology
- Immunology